Apellis Pharmaceuticals, Inc. (APLS)

19.93 -0.60 (-2.92%) USD  |  NASDAQ  |  Jan 16, 16:00
20.05 +0.12 (+0.60%) After-Hours: 20:00
More

Apellis Pharmaceuticals Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade